Clinical trials
Active, not recruiting Diabetes Mellitus, Type 2 trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 4 |
| Alnylam Pharmaceuticals | 1 |
| Amgen | 1 |
| Applied Therapeutics, Inc. | 1 |
| AstraZeneca | 1 |
| Bayer | 1 |
| Corcept Therapeutics | 1 |
| Gaia AG | 1 |
| German Diabetes Center | 1 |
| German Institute of Human Nutrition | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 18 |
| Obesity | 10 |
| Overweight | 7 |
| Diabetes Mellitus | 2 |
| Endocrine System Diseases | 2 |
| Glucose Metabolism Disorders | 2 |
| Metabolic Diseases | 2 |
| Renal Insufficiency, Chronic | 2 |
| ACTH Syndrome, Ectopic | 1 |
| Adrenal Cortex Neoplasms | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.